.svg){kind=small}
Dr Jorg Taubel will be presenting his latest scientific poster presentation on Day 1 from 14h20 to 15h00; Investigating the effect of intravenous APD421 (Amilsulpride) and the ethnic differences between Japanese and Caucasians on cardiac conductionThe theme of this year’s meeting is "Rolling back the frontiers of clinical pharmacology and therapeutics," and its focus will be to revive the spirit of the Society’s founding days and push back the horizons of new clinical pharmacology (and therapeutics) in the 21st century.
-min.jpg)
.jpg)
Latest news
Recruiting breastfeeding mothers into clinical trials through transparent and sensitive conversations
April 30, 2024
Richmond Pharmacology's study on merotocin showed low transfer to breast milk, overcoming recruitment challenges through proximity to a maternity ward.
Read moreAnnouncement of Jorg Becoming President Elect
April 22, 2024
Richmond Pharmacology announces CEO Dr. Jorg Taubel's appointment as President Elect of Germany's AGAH, where he will enhance early-phase clinical research over a six-year term.
Read moreEvents
AHA Hypertension Scientific Sessions 2024
5 - 8 September 2024
Dr. Jörg Taubel, CEO of Richmond Pharmacology, will be attending the Hypertension 2024 Scientific Sessions
View event
